EDP Sciences logo
Subscriber Authentication Point
Rechercher
Menu
Accueil Tous les numéros Volume 42 / Numéro 4 (Avril 2026) Med Sci (Paris), 42 4 (2026) 402-405 References
Issue
Med Sci (Paris)
Volume 42, Number 4, Avril 2026
Nos jeunes pousses ont du talent !
Page(s) 402 - 405
Section Partenariat médecine/sciences - Écoles doctorales - Masters
DOI https://doi.org/10.1051/medsci/2026063
Published online 24 avril 2026
  1. Drucker DJ. Transforming type 1 diabetes: the next wave of innovation. Diabetologia 2021 ; 64 : 1059–1065. [Google Scholar]
  2. Klerk E de, Hebrok M. Stem Cell-Based Clinical Trials for Diabetes Mellitus. Front Endocrinol (Lausanne) 2021 ; 12 : 631463. [Google Scholar]
  3. Memon B, Abdelalim EM. Stem Cell Therapy for Diabetes: Beta Cells versus Pancreatic Progenitors. Cells 2020 ; 9 : 283. [Google Scholar]
  4. Loretelli C, Assi E, Seelam AJ, et al. Cell therapy for type 1 diabetes. Expert Opin Biol Ther 2020 ; 20 : 887–897. [Google Scholar]
  5. Sneddon JB, Tang Q, Stock P, et al. Stem Cell Therapies for Treating Diabetes: Progress and Remaining Challenges. Cell Stem Cell 2018 ; 22 : 810–823. [Google Scholar]
  6. Marfil-Garza BA, Imes S, Verhoeff K, et al. Pancreatic islet transplantation in type 1 diabetes: 20-year experience from a single-centre cohort in Canada. Lancet Diabetes Endocrinol 2022 ; 10 : 519–532. [Google Scholar]
  7. Hogrebe NJ, Ishahak M, Millman JR. Developments in stem cell-derived islet replacement therapy for treating type 1 diabetes. Cell Stem Cell 2023 ; 30 : 530–548. [Google Scholar]
  8. Calafiore R, Luca G, Gaggia F, et al. Human Stem Cell Therapy for the Cure of Type 1 Diabetes Mellitus (T1D): A Hurdle Course between Lights and Shadows. Endocrines 2024 ; 5 : 465–477. [Google Scholar]
  9. Christiansen JR, Kirkeby A. Clinical translation of pluripotent stem cell-based therapies: successes and challenges. Development 2024 ; 151 : dev202067. [Google Scholar]
  10. Kirkeby A, Main H, Carpenter M. Pluripotent stem-cell-derived therapies in clinical trial: A 2025 update. Cell Stem Cell 2025 ; 32 : 10–37. [Google Scholar]
  11. Ghoneim MA, Gabr MM, El-Halawani SM, et al. Current status of stem cell therapy for type 1 diabetes: a critique and a prospective consideration. Stem Cell Res Ther 2024 ; 15 : 23. [Google Scholar]
  12. The Lancet Diabetes Endocrinology null. Stem-cell therapy for diabetes: the hope continues. Lancet Diabetes Endocrinol 2024 ; 12 : 775. [Google Scholar]
  13. Wang S, Du Y, Zhang B, et al. Transplantation of chemically induced pluripotent stem-cell-derived islets under abdominal anterior rectus sheath in a type 1 diabetes patient. Cell 2024 ; 187 : 6152-6164. e18. [Google Scholar]
  14. Keymeulen B, De Groot K, Jacobs-Tulleneers-Thevissen D, et al. Encapsulated stem cell-derived β cells exert glucose control in patients with type 1 diabetes. Nat Biotechnol 2024 ; 42 : 1507–1514. [Google Scholar]
  15. REICHMAN TW, RICORDI C, NAJI A, et al. 836-P: Glucose-Dependent Insulin Production and Insulin-Independence in Type 1 Diabetes from Stem Cell–Derived, Fully Differentiated Islet Cells—Updated Data from the VX-880 Clinical Trial. Diabetes 2023 ; 72 : 836-P. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.